# Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis

> **NCT02732314** · PHASE4 · COMPLETED · sponsor: **Procter & Gamble Beauty** · enrollment: 53 (actual)

## Conditions studied

- Dermatitis, Atopic
- Eczema

## Interventions

- **DRUG:** Investigational OTC Cream
- **OTHER:** Cosmetic Eczema Cream
- **DRUG:** 0.05% Desonide Cream
- **OTHER:** Placebo Cream

## Key facts

- **NCT ID:** NCT02732314
- **Lead sponsor:** Procter & Gamble Beauty
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2016-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02732314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02732314, "Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02732314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*